ROLE OF PLACENTAL AMINOPEPTIDASES DURING PREGNANCY

Paulina Wilczyńska; Barbara Lisowska-Myjak

doi:10.56782/pps.46

Published : 2019-08-07

Vol. 17 No. 1 (2019)

ROLA AMINOPEPTYDAZ ŁOŻYSKOWYCH W PRZEBIEGU CIĄŻY

Paulina Wilczyńska

Barbara Lisowska-Myjak

DOI: https://doi.org/10.56782/pps.46

Abstract

A balanced activity of proteolytic enzymes is a prerequisite for the preservation of homeostasis in the intrauterine environment of the fetus. Aminopeptidases produced in the placenta are exopeptidases that remove N-terminal amino acid residues from a polypeptide chain. These proteolytic enzymes differ both in their localization in placental cells and in their substrate specificity. The major biological role of placental aminopeptidases is the inactivation of metabolically active peptides, a process crucial for the control of adverse metabolic changes during pregnancy. The preservation of a placental barrier prevents the transfer of vasoactive peptides produced by the fetus (oxytocin, angiotensin II, vasopressin) to the mother, resulting in the ability to maintain a normal maternal blood pressure, to control uterine contractility, and to prevent preterm delivery. Reduced activity of aminopeptidases in the placenta leads to uncontrolled increases in the transfer of vasoactive peptides to the mother and as a consequence, to vasospasm-associated complications of pregnancy. This paper discusses the physiological role of placental aminopeptidases in normal pregnancy and the involvement of their abnormal activities in complications of pregnancy such as preeclampsia, gestational hypertension or preterm delivery. This is a literature review focusing on articles published in English between 1988 and 2017, and available in PubMed. The following search terms were used: placental proteases, placental aminopeptidases, preeclampsia, gestational hypertension, premature delivery.

Keywords:

placental proteases, placental aminopeptidases, gestational hypertension, premature delivery

Similar Articles

Iwona Lewandowska Lewandowska, Monika Zielińska-Pisklak, Łukasz Szeleszczuk, Dariusz Maciej Pisklak, Marcin Sobczak, PULMONARY HYPERTENSION — PATHOPHYSIOLOGY AND DRUGS USED IN THERAPY , Prospects in Pharmaceutical Sciences: Vol. 18 No. 2 (2020)
Anna Lis, Paulina Lis, Wojciech Kaźmierski, Kinga Kocur, Katarzyna Camlet, Jakub Jurek, Mateusz Ziomek, Anna Ziobro, Sodium bicarbonate - known medication, new prospects? , Prospects in Pharmaceutical Sciences: Vol. 22 No. 3 (2024)
Karolina Gimpel, Piotr Luliński, Dorota Maciejewska, SELECTED SYSTEMS OPTIMIZING DRUG DELIVERY , Prospects in Pharmaceutical Sciences: Vol. 7 No. 3 (2009)
Bartłomiej Kot, Mateusz Moczulski, Agnieszka Czajkowska, Arkadiusz Kocur, Pharmacotherapy of apnea in the premature neonatological subpopulation – therapeutic opportunities, pharmacokinetic implications and recommendations for therapeutic drug monitoring , Prospects in Pharmaceutical Sciences: Vol. 22 No. 2 (2024)
Aleksandra Laskus, Joanna K olmas, NOVEL HYDROXYAPATITE-BASED ANTIBIOTIC DELIVERY SYSTEMS TARGETING BONES , Prospects in Pharmaceutical Sciences: Vol. 14 No. 1 (2016)
Adam Piasecki, Magdalena Sitnik, Jakub Olszewski, Maciej Bara, Katarzyna Herjan, Piotr Armański, The changing landscape of mineralocorticoid receptor antagonists – finerenone in cardiovascular and renal health , Prospects in Pharmaceutical Sciences: Vol. 22 No. 1 (2024)
Michał Gackowski, Katarzyna Połomska, Natalia Szczucka, Mateusz Wylaź, Digital-based system as a tool for improving healthcare coordination - a perspective study , Prospects in Pharmaceutical Sciences: Vol. 22 No. 2 (2024)
Ewa Napiórkowska, Overview of cyclodextrins and medicinal products containing cyclodextrins currently registered in Poland , Prospects in Pharmaceutical Sciences: Vol. 21 No. 3 (2023)
Falah Saleh Mohammed, Mustafa Sevindik, İmran Uysal, Ali Erdem Sabik, Quercetin: derivatives, biosynthesis, biological activity, pharmacological and therapeutic effects , Prospects in Pharmaceutical Sciences: Vol. 21 No. 3 (2023)
Sylwia Kraczkowska, Zofia Suchocka, Jan Pachecka, ELEVATED BLOOD LEVEL OF HOMOCYSTEINE AS INDICATOR OF HEALTH HAZARD , Prospects in Pharmaceutical Sciences: Vol. 3 No. 3 (2005)

1 2 > >>

You may also start an advanced similarity search for this article.

Details

References

Statistics

Authors

Download files

PDF (Język Polski)

Citation rules

Wilczyńska, P., & Lisowska-Myjak, B. (2019). ROLA AMINOPEPTYDAZ ŁOŻYSKOWYCH W PRZEBIEGU CIĄŻY. Prospects in Pharmaceutical Sciences, 17(1), 1–5. https://doi.org/10.56782/pps.46

Altmetric indicators

Cited by / Share

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

Rawlings ND, Barrett AJ, Finn R. Twenty years of the MEROPS database of proteolytic enzymes, their substrates and inhibitors. Nucleic Acids Res. 2016, 44(D1), D343-350. DOI: https://doi.org/10.1093/nar/gkv1118

Sanderink GJ, Artur Y, Siest G. Human aminopeptidases: a review of the literature. J Clin Chem Clin Biochem. 1988, 26(12), 795-807. DOI: https://doi.org/10.1515/cclm.1988.26.12.795

Gonzales T, Robert-Baudouy J. Bacterial aminopeptidases: properties and functions. FEMS Microbiol Rev. 1996, 18(4), 319-344. DOI: https://doi.org/10.1111/j.1574-6976.1996.tb00247.x

Gard PR, Fidalgo S, Lotter I, Richardson C, Farina N, Rusted J, Tabet N. Changes of renin-angiotensin system-related aminopeptidases in early stage Alzheimer's disease. Exp Gerontol. 2017, 89, 1-7. DOI: https://doi.org/10.1016/j.exger.2017.01.006

Mizutani S. Physiological roles of placental proteases in feto-placental homeostasis. Nagoya J Med Sci. 1998, 61(3-4), 85-95.

Mizutani S, Tomoda Y. Effects of placental proteases on maternal and fetal blood pressure in normal pregnancy and preeclampsia. Am J Hypertens. 1996, 9(6), 591-597.

Johnson MP, Roten LT, Dyer TD, East CEt, Forsmo S, Blangero J, Brennecke SP, Austgulen R, Moses EK. The ERAP2 gene is associated with preeclampsia in Australian and Norwegian populations. Hum Genet. 2009, 126(5), 655-666. DOI: https://doi.org/10.1007/s00439-009-0714-x

Horie A, Fujiwara H, Sato Y, Suginami K, Matsumoto H, Maruyama M, Konishi I, Hattori A. Laeverin/aminopeptidase Q induces trophoblast invasion during human early placentation. Hum Reprod. 2012, 27, 1267–1276. DOI: https://doi.org/10.1093/humrep/des068

Nomura M, Tsukahara S, Ando H, Katsumata Y, Okada M, Itakura A, Nomura S, Kikkawa F, Nagasaka T, Mizutani S. Differential distribution of placental leucine aminopeptidase/oxytocinase and aminopeptidase A in human trophoblasts of normal placenta and complete hydatidiform mole. Placenta. 2002, 23(8-9), 631-639. DOI: https://doi.org/10.1053/plac.2002.0861

Nagasaka T, Nomura S, Okamura M, Tsujimoto M, Nakazato H, Oiso Y, Nakashima N, Mizutani S. Immunohistochemical localization of placental leucine aminopeptidase/oxytocinase in normal human placental, fetal and adult tissues. Reprod Fertil Dev. 1997, 9(8), 747-53. DOI: https://doi.org/10.1071/R97055

Mizutani S, Wright JW, Kobayashi H. Placental leucine aminopeptidase- and aminopeptidase A- deficient mice offer insight concerning the mechanisms underlying preterm labor and preeclampsia. J Biomed Biotechnol. 2011, Article ID 286947, 1-12. DOI: https://doi.org/10.1155/2011/286947

Gao J, Marc Y, Iturrioz X, Leroux V, Balavoine F, Llorens-Cortes C. A new strategy for treating hypertension by blocking the activity of the brain renin-angiotensin system with aminopeptidase A inhibitors. Clin Sci 2014, 127(3), 135-148. DOI: https://doi.org/10.1042/CS20130396

Mizutani S, Tomoda Y. Effects of placental proteases on maternal and fetal blood pressure in normal pregnancy and preeclampsia. Am J Hypertens. 1996, 9(6), 591-597. DOI: https://doi.org/10.1016/0895-7061(96)00016-7

Mizutani S, Wright J, Kobayashi H. A new approach regarding the treatment of preeclampsia and preterm labor. Life Sci. 2011, 88(1-2), 17-23. DOI: https://doi.org/10.1016/j.lfs.2010.10.013

Tian C, Huang Z, Wen Z. Associations between serum placental leucine aminopeptidase and pregnancy outcomes. Int J Gynaecol Obstet. 2016, 135(3), 255-258. DOI: https://doi.org/10.1016/j.ijgo.2016.05.016

Toda S, Ando H, Nagasaka T, Tsukahara S, Nomura M, Kotani Y, Nomura S, Kikkawa F, Tsujimoto M, Mizutani S. Existence of placental leucine aminopeptidase/oxytocinase/insulin-regulated membrane aminopeptidase in human endometrial epithelial cells. J Clin Endocrinol Metab. 2002, 87(3), 1384-1389. DOI: https://doi.org/10.1210/jcem.87.3.8306

Matsumoto H, Mori T. Changes in cystine aminopeptidase (oxytocinase) activity in mouse serum, placenta, uterus and liver during pregnancy or after steroid hormone treatments. Zoolog Sci. 1998, 15(1), 111-115. DOI: https://doi.org/10.2108/zsj.15.111

Mizutani S, Naruse K, Hattori A, Tsujimoto M, Kobayashi H. Physiological and pathophysiological roles of placental aminopeptidase in maternal sera: possible relation to preeclampsia and preterm delivery. Expert Opin Med Diagn. 2009, 3(5), 479-491. DOI: https://doi.org/10.1517/17530050903074556

Chauvel EN, Coric P, Llorens-Cortès C, Wilk S, Roques BP, Fournié-Zaluski MC. Investigation of the active site of aminopeptidase A using a series of new thiol-containing inhibitors. J Med Chem. 1994, 37(9), 1339-1346. DOI: https://doi.org/10.1021/jm00035a014

Cilia La Corte AL, Carter AM, Turner AJ, Grant PJ, Hooper NM. The bradykinin-degrading aminopeptidase P is increased in women taking the oral contraceptive pill. J Renin Angiotensin Aldosterone Syst. 2008, 9(4), 221-225. DOI: https://doi.org/10.1177/1470320308096405

Lee ED. Endoplasmic Reticulum Aminopeptidase 2, a common immunological link to adverse pregnancy outcomes and cancer clearance? Placenta. 2017, 56, 40-43. DOI: https://doi.org/10.1016/j.placenta.2017.03.012

Maruyama M, Hattori A, Goto Y, Ueda M, Maeda M, Fujiwara H, Tsujimoto M. Laeverin/aminopeptidase Q, a novel bestatin-sensitive leucine aminopeptidase belonging to the M1 family of aminopeptidases. J Biol Chem. 2007, 282(28), 20088-20096. DOI: https://doi.org/10.1074/jbc.M702650200

Mizutani S, Goto K, Mizuno K, Itakura A, Kurauchi O, Kikkawa F, Tomoda Y. Interaction between pregnancy-induced bioactive peptides and the placental proteases. Reprod Fertil Dev. 1995, 7(6), 1431-1436. DOI: https://doi.org/10.1071/RD9951431

Landau R, Laverrière A, Bischof P, Irion O, Morales M, Cohen M. Alteration of circulating Placental Leucine Aminopeptidase (P-LAP) activity in preeclampsia. Neuro Endocrinol Lett. 2010, 31(1), 63-66.

Kattah AG, Garovic VD. The management of hypertension in pregnancy. Adv Chronic Kidney Dis. 2013, 20(3), 229-239. DOI: https://doi.org/10.1053/j.ackd.2013.01.014

Etelvino GM, Peluso AA, Santos RA. New components of the renin-angiotensin system: alamandine and the MAS-related G protein-coupled receptor D. Curr Hypertens Rep. 2014, 16(6), 433-439. DOI: https://doi.org/10.1007/s11906-014-0433-0

Morishita R, Higaki J, Okunishi H, Kawamoto T, Ishii K, Nakamura F, Katahira K, Nagano M, Mimami H, Miyazaki M, Ogihara T. Effect of long-term treatment with an angiotensin-converting enzyme inhibitor on the renin-angiotensin system in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 1991, 18, 685-690. DOI: https://doi.org/10.1111/j.1440-1681.1991.tb01381.x

Goldenberg RL, Goepfert AR, Ramsey PS. Biochemical markers for the prediction of preterm birth. Am J Obstet Gynecol. 2005, 192(5 Suppl), S36-46. DOI: https://doi.org/10.1016/j.ajog.2005.02.015

Di Renzo GC, Roura LC, Facchinetti F, Antsaklis A, Breborowicz G, Gratacos E, Husslein P, Lamont R, Mikhailov A, Montenegro N, Radunovic N, Robson M, Robson SC, Sen C, Shennan A, Stamatian F, Ville Y. Guidelines for the management of spontaneous preterm labor: identification of spontaneous preterm labor, diagnosis of preterm premature rupture of membranes, and preventive tools for preterm birth. J Matern Fetal Neonatal Med. 2011, 24(5), 659-667. DOI: https://doi.org/10.3109/14767058.2011.553694

Paulina Wilczyńska

Affiliation:

Katedra Biochemii i Chemii Klinicznej, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej, Warszawski Uniwersytet Medyczny, ul. Banacha 1, 02-097 Warszawa Poland

Bio Statement (e.g., department and rank)

autorka korespondująca, tel: +48 22 572 0735

Barbara Lisowska-Myjak

Affiliation:

Warszawski Uniwersytet Medyczny, ul. Banacha 1, 02-097 Warszawa Poland

ROLA AMINOPEPTYDAZ ŁOŻYSKOWYCH W PRZEBIEGU CIĄŻY

Paulina Wilczyńska

Barbara Lisowska-Myjak

Abstract

Keywords:

Most read articles by the same author(s)

Similar Articles

Paulina Wilczyńska

Barbara Lisowska-Myjak